Gabelli Funds’s Acceleron Pharma XLRN Stock Holding History

Gabelli Funds’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-60,572	Closed	-$10.4M	–	1478
2021 Q3	$10.4M	Buy	+60,572	New	+$7.92M	0.07%	332

Gabelli Funds's XLRN Position: Q4 2021 in Review

Gabelli Funds sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 60,572 shares — an estimated $10.4M sold.

Gabelli Funds first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $10.4M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Gabelli Funds reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Gabelli Funds sold 60,572 Acceleron Pharma shares in Q4 2021, an estimated $10.4M.
Gabelli Funds first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Gabelli Funds's Acceleron Pharma position peaked at $10.4M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Gabelli Funds's 13F filing for Q4 2021, filed 11 Feb 2022.